Parabilis Medicines
Drug DiscoveryWebsite
Developer of cell-penetrating mini proteins (CPMPs) designed to target cancer-causing proteins inside cancer cells and neutralize them. The company's mini proteins (CPMPs) are a broad new class of med...
Valuation
$400M
Market implied
Share Price
N/A
Total Raised
$507M
Last Round
Later Stage VC (Series F)
Jan 2026
Latest Funding Round
Later Stage VC (Series F)
Jan 8, 2026
$305M
raised
Investors
+34 other investors